22 days ago
KRYS
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 10%
#474 out of 5186 analysts
Average Return
+7.52%
Win Rate
45%124 out of 275
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-04 - 2024-04-04 | Strong Buy |
Olema Pharmaceuticals IncOLMA | +383.05% | $5.31 | $25.65 | 2025-08-11 - 2026-02-02 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-17 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-08 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-23 - 2024-02-26 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
25 days ago
ARDX
25 days ago
KRYS
a month ago
ARVN
a month ago
KRYS
2 months ago
OLMA
3 months ago
ORIC
3 months ago
ONC
3 months ago
CRBU
3 months ago
NBIX
3 months ago
ZBIO
4 months ago
RCUS
6 months ago
ARCT
6 months ago
OLMA
6 months ago
ZLAB
6 months ago
ZYME
6 months ago
LXRX
6 months ago
SNDX
6 months ago
LENZ
6 months ago
LENZ
7 months ago
PROK
10 months ago
SMMT
10 months ago
LENZ
a year ago
RIGL
a year ago
MRUS
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Krystal Biotech IncKRYS | 10 | Strong Buy | $336.00 | +19.03% | Maintains | 22 days ago |
Ardelyx IncARDX | 13 | Strong Buy | $14.00 | +79.72% | Maintains | 25 days ago |
Shattuck Labs IncSTTK | 5 | Hold | $4.00 | +3.90% | Maintains | a month ago |
Arcturus Therapeutics Holdings IncARCT | 9 | Hold | $7.00 | -5.02% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 2 | Strong Buy | $36.00 | +37.77% | Maintains | a month ago |
Arvinas IncARVN | 10 | Strong Buy | $15.00 | +8.46% | Upgrades | a month ago |
Olema Pharmaceuticals IncOLMA | 3 | Strong Buy | $60.00 | +133.92% | Maintains | 2 months ago |
Alpha Tau Medical LtdDRTS | 1 | Strong Buy | $7.00 | +0.57% | Maintains | 2 months ago |
Ligand Pharmaceuticals IncLGND | 1 | Strong Buy | $270.00 | +36.41% | Initiates Coverage On | 2 months ago |
Oric Pharmaceuticals IncORIC | 6 | Strong Buy | $16.00 | +43.37% | Maintains | 3 months ago |
Candel Therapeutics IncCADL | 2 | Strong Buy | $24.00 | +308.86% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 19 | Strong Buy | $77.00 | +50.07% | Maintains | 3 months ago |
Arrivent Biopharma IncAVBP | 4 | Strong Buy | $31.00 | +36.74% | Maintains | 3 months ago |
Biomea Fusion IncBMEA | 11 | Strong Buy | $6.00 | +445.45% | Maintains | 3 months ago |
Beone Medicines LtdONC | 5 | Strong Buy | $405.00 | +17.39% | Maintains | 3 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $14.00 | +117.73% | Maintains | 3 months ago |
Caribou Biosciences IncCRBU | 6 | Strong Buy | $8.00 | +447.95% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 16 | Strong Buy | $45.00 | +97.11% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 8 | Strong Buy | $56.00 | +158.54% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $203.00 | +47.50% | Maintains | 3 months ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $46.00 | +153.44% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 6 | Strong Buy | $40.00 | +184.50% | Maintains | 3 months ago |
Merus NvMRUS | 15 | Hold | $97.00 | +7.78% | Downgrades | 4 months ago |
Zai Lab LtdZLAB | 8 | Strong Buy | $69.00 | +323.31% | Maintains | 6 months ago |
Zymeworks IncZYME | 13 | Strong Buy | $22.00 | -5.05% | Maintains | 6 months ago |
Lexicon Pharmaceuticals IncLXRX | 6 | Strong Buy | $1.90 | +52.00% | Maintains | 6 months ago |
Syndax Pharmaceuticals IncSNDX | 9 | Strong Buy | $51.00 | +138.88% | Maintains | 6 months ago |
Lenz Therapeutics IncLENZ | 4 | Strong Buy | $52.00 | +219.02% | Maintains | 6 months ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Sell | $7.00 | -66.22% | Initiates Coverage On | 6 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $9.00 | +341.18% | Maintains | 7 months ago |
Rigel Pharmaceuticals IncRIGL | 11 | Strong Buy | $55.00 | +52.74% | Maintains | a year ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | a year ago |
Applied Therapeutics IncAPLT | 8 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $58.00 | N/A | Maintains | a year ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | N/A | Maintains | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | N/A | Downgrades | 2 years ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | N/A | Downgrades | 2 years ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 4 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | 3 years ago |
Unity Biotechnology IncUNBX | 6 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Opthea LtdOPTEY | 2 | Strong Buy | $44.00 | N/A | Maintains | 3 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 5 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 7 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.